PYRROLOBENZODIAZEPINKONJUGATE

European patent · EP3668874 · In force

Register entry

Publication number
EP3668874
Application number
EP18758581
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 17, 2018
Published
Jun 24, 2020
Granted
Dec 22, 2021
Protection ends at the latest
Aug 16, 2038
Next annual fee due
Aug 31, 2026
IPC classes
A61K 31/5517 (2006.01)
C07K 16/30 (2006.01)
A61K 47/68 (2017.01)
A61K 45/06 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
C07K 16/32 (2006.01)
C07D 519/00 (2006.01)
C07D 487/04 (2006.01)
Priority
US 201762547303 P 18.08.2017
PCT application
PCT/EP2018/072298 17.08.2018
PCT publication
WO2019/034764 21.02.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Nov 2, 2022

    Change

    Published in Swissreg on 02.11.2022

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Feb 18, 2022

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 18.02.2022

  7. Dec 22, 2021

    Granted

    Published in Swissreg on 22.12.2021

Parties

Inventor

TIBERGHIEN, Arnaud Charles

Cambridge Cambridgeshire CB21 6GH, GB

VIJAYAKRISHNAN, Balakumar

Cambridge Cambridgeshire CB21 6GH, GB

WHITE, Jason

Gaithersburg, MD 20878, US

MASTERSON, Luke

Cambridge Cambridgeshire CB21 6GH, GB

HOWARD, Philip Wilson

Cambridge Cambridgeshire CB21 6GH, GB

DIMASI, Nazzareno

Gaithersburg, MD 20878, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.